That elevated PrPC may confer resistance to anticancer agents was soon confirmed by the demonstration of a causal relationship between increased PrPC expression and resistance to tumour necrosis factor-α (TNFα) in the MCF7 breast cancer cell line [50]. The gene discussed is TNF; the disease is breast carcinoma.